Brenda Ernst

815 total citations
30 papers, 397 citations indexed

About

Brenda Ernst is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Brenda Ernst has authored 30 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Cancer Research and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Brenda Ernst's work include Breast Cancer Treatment Studies (6 papers), Advanced Breast Cancer Therapies (4 papers) and Cancer survivorship and care (3 papers). Brenda Ernst is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Advanced Breast Cancer Therapies (4 papers) and Cancer survivorship and care (3 papers). Brenda Ernst collaborates with scholars based in United States, Brazil and United Kingdom. Brenda Ernst's co-authors include Karen S. Anderson, Barbara A. Pockaj, Patricia A. Cronin, Heidi Kosiorek, Donald W. Northfelt, Bhavika Patel, Ann E. McCullough, Carlos Caldas, Suet‐Feung Chin and Ahuva Odenheimer-Bergman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Brenda Ernst

28 papers receiving 390 citations

Peers

Brenda Ernst

ONCOL

PRM

PFM

Claudia Arce-Salinas Mexico

Ahmed Elkhanany United States

Lubna N. Chaudhary United States

Tessa G. Steenbruggen Netherlands

Joan B. Heijns Netherlands

Do Youn Oh South Korea

Constanta Timcheva United Kingdom

Rebecca Shatsky United States

Xiaojun Fan China

Bilge Aktaş Türkiye

Claudia Arce-Salinas Mexico

Brenda Ernst

177 ×0.8

241 ×1.2

ONCOL

138 ×1.0

80 ×0.7

PRM

47 ×0.8

PFM

Citations per year, relative to Brenda Ernst Brenda Ernst (= 1×) peers Claudia Arce-Salinas

Countries citing papers authored by Brenda Ernst

Since Specialization

Citations

This map shows the geographic impact of Brenda Ernst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brenda Ernst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brenda Ernst more than expected).

Fields of papers citing papers by Brenda Ernst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brenda Ernst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brenda Ernst. The network helps show where Brenda Ernst may publish in the future.

Co-authorship network of co-authors of Brenda Ernst

This figure shows the co-authorship network connecting the top 25 collaborators of Brenda Ernst. A scholar is included among the top collaborators of Brenda Ernst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brenda Ernst. Brenda Ernst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gouveia, Maria João, et al.. (2025). Cyclin-dependent kinase 4/6 inhibitors beyond progression in hormone receptor-positive, HER2-negative advanced breast cancer: a systematic review and meta-analysis (REIGNITE study). ESMO Open. 10(10). 105808–105808.

Haddad, Tufia C., Vera J. Suman, Karthik V. Giridhar, et al.. (2024). Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Early-Stage Breast Cancer: A Prospective Trial. Clinical Cancer Research. 30(15). 3147–3156. 3 indexed citations

Patel, Bhavika, Donald W. Northfelt, Karen S. Anderson, et al.. (2024). Prospective Study of Supplemental Screening With Contrast-Enhanced Mammography in Women With Elevated Risk of Breast Cancer: Results of the Prevalence Round. Journal of Clinical Oncology. 42(32). 3826–3836. 10 indexed citations

Vern-Gross, T.Z., Brenda Ernst, Natalie R. Langley, et al.. (2024). Implementation of the REFLECT Communication Curriculum for Clinical Oncology Graduate Medical Education. Journal of Palliative Medicine. 27(2). 231–235. 2 indexed citations

Ernst, Brenda, et al.. (2024). Lifestyle Factors and Cancer: A Narrative Review. SHILAP Revista de lepidopterología. 8(2). 166–183. 14 indexed citations

Ernst, Brenda, et al.. (2024). QTc prolongation across CDK4/6 inhibitors: a systematic review and meta-analysis of randomized controlled trials. JNCI Cancer Spectrum. 8(5). 3 indexed citations

Haddad, Tufia C., Vera J. Suman, Karthik V. Giridhar, et al.. (2023). Abstract OT1-04-02: Anastrozole dose escalation for optimal estrogen suppression in postmenopausal early stage breast cancer: A prospective trial. Cancer Research. 83(5_Supplement). OT1–4. 1 indexed citations

Clark, Kaylee M., Alvaro Moreno‐Aspitia, Brenda Ernst, et al.. (2023). Abstract P4-07-56: Mayo Clinic Enterprise patterns of growth-factor utilization for sacituzumab govitecan (SG)-induced neutropenia among patients with metastatic triple negative breast cancer. Cancer Research. 83(5_Supplement). P4–7. 3 indexed citations

Langley, Natalie R., Samir H. Patel, Brenda Ernst, et al.. (2023). Attitudes and Perception of the REFLECT Communication Curriculum for Clinical Oncology Graduate Medical Education. Journal of Cancer Education. 38(6). 1786–1791. 2 indexed citations

10.

Tofthagen, Cindy, Adam Perlman, Pooja Advani, et al.. (2022). Medical Marijuana Use for Cancer-Related Symptoms among Floridians: A Descriptive Study. Journal of Palliative Medicine. 25(10). 1563–1570. 7 indexed citations

11.

Mina, Lida A., et al.. (2022). PARP Inhibitors for Breast Cancer: Germline BRCA1/2 and Beyond. Cancers. 14(17). 4332–4332. 31 indexed citations

12.

Singh, Komal, Keenan A. Pituch, Qiyun Zhu, et al.. (2022). Distinct Nausea Profiles Are Associated With Gastrointestinal Symptoms in Oncology Patients Receiving Chemotherapy. Cancer Nursing. 46(2). 92–102. 5 indexed citations

13.

Singh, Komal, Kord M. Kober, Brenda Ernst, et al.. (2021). Multiple Gastrointestinal Symptoms Are Associated With Chemotherapy-Induced Nausea in Patients With Breast Cancer. Cancer Nursing. 45(3). 181–189. 10 indexed citations

14.

Kosiorek, Heidi, Richard J. Gray, Brenda Ernst, et al.. (2021). Characterizing Occult Nodal Disease Within a Clinically Node-Negative, Neoadjuvant Breast Cancer Population. Clinical Breast Cancer. 22(2). 186–190. 2 indexed citations

15.

Kosiorek, Heidi, Barbara A. Pockaj, Brenda Ernst, et al.. (2020). Gauging the efficacy of neoadjuvant endocrine therapy in breast cancer patients with known axillary disease. Journal of Surgical Oncology. 122(4). 619–622. 11 indexed citations

16.

McDonald, Bradon R., Tania Contente‐Cuomo, Stephen‐John Sammut, et al.. (2019). Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer. Science Translational Medicine. 11(504). 201 indexed citations

17.

Sokol, Ethan, Lee A. Albacker, Aixa Soyano, et al.. (2019). Abstract 4894: Incidence of high tumor mutation burden (TMB) and PD-L1 positivity in breast cancers and potential response to immune checkpoint inhibitors (ICPIs). Cancer Research. 79(13_Supplement). 4894–4894. 3 indexed citations

18.

Padrnos, Leslie, Brenda Ernst, Amylou C. Dueck, et al.. (2018). A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 18(10). 664–672.e2. 6 indexed citations

19.

Ernst, Brenda & Karen S. Anderson. (2015). Immunotherapy for the Treatment of Breast Cancer. Current Oncology Reports. 17(2). 5–5. 54 indexed citations

20.

Ernst, Brenda, et al.. (1965). [Immunohistological, histological and bacteriological studies of acute experimental coli-pyelonephritis of the rat treated with sulfisomidine and prednisolone].. PubMed. 15(4). 480–91. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact